A Systematic Review and Meta-Analysis of Mirnas for the Detection of Cervical Cancer

References

• Singh D , VignatJ , LorenzoniVet al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob. Health11(2), e197–e206 (2022).
   PubMed Web of Science ®Google Scholar
• Public Health England . Guidance: cervical screening: programme overview (2023). www.gov.uk/guidance/cervical-screening-programme-overview
   Google Scholar
• Kitchener HC , AlmonteM , ThomsonCet al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol.10(7), 672–682 (2009).
   PubMed Web of Science ®Google Scholar
• Castle PE , StolerMH , WrightTCJret al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol.12(9), 880–890 (2011).
   PubMed Web of Science ®Google Scholar
• Doorbar J , EgawaN , GriffinH , KranjecC , MurakamiI. Human papillomavirus molecular biology and disease association. Rev. Med. Virol.25(Suppl. 1), 2–23 (2015).
   PubMed Web of Science ®Google Scholar
• Harden ME , MungerK. Human papillomavirus molecular biology. Mutat. Res. Rev. Mutat. Res.772, 3–12 (2017).
   PubMed Web of Science ®Google Scholar
• Clifford GM , TullyS , FranceschiS. Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clin. Infect. Dis.64(9), 1228–1235 (2017).
   PubMed Web of Science ®Google Scholar
• Pal A , KunduR. Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy. Front. Microbiol.10, 3116 (2019).
   PubMed Web of Science ®Google Scholar
• Szymonowicz KA , ChenJ. Biological and clinical aspects of HPV-related cancers. Cancer Biol. Med.17(4), 864–878 (2020).
   PubMed Web of Science ®Google Scholar
• McCredie MR , PaulC , SharplesKJet al. Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3. Aust. N. Z. J. Obstet. Gynaecol.50(4), 363–370 (2010).
   PubMed Web of Science ®Google Scholar
• Munoz N , CastellsagueX , Berringtonde González A , GissmannL. Chapter 1: HPV in the etiology of human cancer. Vaccine24(Suppl. 3), S1–10 (2006).
   PubMedGoogle Scholar
• Myers ER , McCroryDC , NandaKet al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am. J. Epidemiol.151(12), 1158–1171 (2000).
   PubMed Web of Science ®Google Scholar
• Plummer M , SchiffmanM , CastlePEet al. ALTS Group . A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis.195(11), 1582–1589 (2007).
   PubMed Web of Science ®Google Scholar
• Liebenberg LJP , McKinnonLR , Yende-ZumaNet al. HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition. Nat. Commun.10(1), 5227 (2019).
   PubMedGoogle Scholar
• Li B , ZhangL , ZhaoJet al. The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cervix. Infect. Agent Cancer14, 16 (2019).
   PubMed Web of Science ®Google Scholar
• Steele JC , RobertsS , RookesSM , GallimorePH. Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release. J. Virol.76(12), 6027–6036 (2002).
   PubMed Web of Science ®Google Scholar
• Stanley M . Immune responses to human papillomavirus. Vaccine24(Suppl. 1), S16–22 (2006).
   PubMed Web of Science ®Google Scholar
• Brusselaers N , ShresthaS , vande Wijgert J , VerstraelenH. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am. J. Obstet. Gynecol.221(1), 9–18.e8 (2019).
   PubMed Web of Science ®Google Scholar
• Norenhag J , DuJ , OlovssonMet al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG127(2), 171–180 (2020).
   PubMed Web of Science ®Google Scholar
• Mens MMJ , GhanbariM. Cell cycle regulation of stem cells by MicroRNAs. Stem Cell Rev. Rep.14(3), 309–322 (2018).
   PubMed Web of Science ®Google Scholar
• Lenkala D , LacroixB , GamazonERet al. The impact of microRNA expression on cellular proliferation. Hum. Genet.133(7), 931–938 (2014).
   PubMed Web of Science ®Google Scholar
• Yao S . MicroRNA biogenesis and their functions in regulating stem cell potency and differentiation. Biol. Proced. Online18, 8 (2016).
   PubMed Web of Science ®Google Scholar
• Zhou W , SuL , DuanXet al. MicroRNA-21 down-regulates inflammation and inhibits periodontitis. Mol. Immunol.101, 608–614 (2018).
   PubMed Web of Science ®Google Scholar
• Taghavipour M , SadoughiF , MirzaeiHet al. Apoptotic functions of microRNAs in pathogenesis, diagnosis, and treatment of endometriosis. Cell Biosci.10, 12 (2020).
   PubMed Web of Science ®Google Scholar
• Macfarlane LA , MurphyPR. MicroRNA: biogenesis, function and role in cancer. Curr. Genomics11(7), 537–561 (2010).
   PubMed Web of Science ®Google Scholar
• Perron MP , ProvostP. Protein interactions and complexes in human microRNA biogenesis and function. Front. Biosci.13, 2537–2547 (2008).
   PubMed Web of Science ®Google Scholar
• Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116(2), 281–297 (2004).
   PubMed Web of Science ®Google Scholar
• Peng Y , CroceCM. The role of MicroRNAs in human cancer. Signal Transduct. Target Ther.1, 1–9 (2016).
   Web of Science ®Google Scholar
• Esquela-Kerscher A , SlackFJ. Oncomirs – microRNAs with a role in cancer. Nat. Rev. Cancer6(4), 259–269 (2006).
   PubMed Web of Science ®Google Scholar
• Loh HY , NormanBP , LaiKSet al. The regulatory role of microRNAs in breast cancer. Int. J. Mol. Sci.20(19), 4940 (2019).
   PubMed Web of Science ®Google Scholar
• Norouzi S , FarhadiA , FarzadfardEet al. MicroRNAs expression changes coincide with low or high grade of squamous intraepithelial lesion infected by HPV-16. Gene Rep.23, doi: 10.1016/j.genrep.2021.101186 (2021).
   Web of Science ®Google Scholar
• Nunvar J , PagacovaL , VojtechovaZet al. Lack of conserved miRNA deregulation in HPV-induced squamous cell carcinomas. Biomolecules11(5), 764 (2021).
   PubMed Web of Science ®Google Scholar
• Tong F , AndressA , TangG , LiuP , WangX. Comprehensive profiling of extracellular RNA in HPV-induced cancers using an improved pipeline for small RNA-seq analysis. Sci. Rep.10(1), 1–13 (2020).
   PubMed Web of Science ®Google Scholar
• Xia YF , PeiGH , WangNet al. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA. Virol. J.14(1), 20 (2017).
   PubMedGoogle Scholar
• Han MS , LeeJM , KimSNet al. Human papillomavirus 16 oncoproteins downregulate the expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in cervical cancer. Biomed. Res. Int.2018, doi: 10.1155/2018/1942867 (2018).
   Web of Science ®Google Scholar
• Kyrgiou M , KoliopoulosG , Martin-HirschPet al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet367(9509), 489–498 (2006).
   PubMed Web of Science ®Google Scholar
• Arbyn M , KyrgiouM , SimoensCet al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ337, doi: 10.1136/bmj.a1284 (2008).
   PubMedGoogle Scholar
• Jakobsson M , GisslerM , SainioSet al. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet. Gynecol.109(2 Pt 1), 309–313 (2007).
   PubMed Web of Science ®Google Scholar
• Noehr B , JensenA , FrederiksenKet al. Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am. J. Obstet. Gynecol.201(1), 33.e1–6 (2009).
   PubMed Web of Science ®Google Scholar
• Kelly H , MayaudP , SegondyMet al. A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening. Sex Transm. Infect.93(Suppl. 4), S36–S45 (2017).
   PubMedGoogle Scholar
• Kilgour E , RothwellDG , BradyG , DiveC. Liquid biopsy-based biomarkers of treatment response and resistance. Cancer Cell37(4), 485–495 (2020).
   PubMed Web of Science ®Google Scholar
• Barault L , AmatuA , SiravegnaGet al. Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut67(11), 1995–2005 (2018).
   PubMed Web of Science ®Google Scholar
• Xu RH , WeiW , KrawczykMet al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat. Mater.16(11), 1155–1161 (2017).
   PubMed Web of Science ®Google Scholar
• Hillyar CR , KanabarSS , PufalKRet al. A systematic review and meta-analysis of the diagnostic effectiveness of human papillomavirus methylation biomarkers for detection of cervical cancer. Epigenomics14(18), 1055–1072 (2022).
   PubMed Web of Science ®Google Scholar
• Shen S , ZhangS , LiuP , WangJ , DuH. Potential role of microRNAs in the treatment and diagnosis of cervical cancer. Cancer Genet.248–249, 25–30 (2020).
   PubMed Web of Science ®Google Scholar
• Lupandin VI , SurninaOE. [Asymmetry of time distribution of simple sensory motor reaction]. Fiziol. Cheloveka14(4), 700–702 (1988).
   PubMedGoogle Scholar
• Bramer WM , GiustiniD , KramerBM. Comparing the coverage, recall, and precision of searches for 120 systematic reviews in Embase, MEDLINE, and Google Scholar: a prospective study. Syst. Rev.5, 39 (2016).
   PubMedGoogle Scholar
• Frandsen TF , EriksenMB , HammerDMGet al. Using Embase as a supplement to PubMed in Cochrane reviews differed across fields. J. Clin. Epidemiol.133, 24–31 (2021).
   PubMed Web of Science ®Google Scholar
• Falagas ME , PitsouniEI , MalietzisGA , PappasG. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J.22(2), 338–342 (2008).
   PubMed Web of Science ®Google Scholar
• Moher D , LiberatiA , TetzlaffJAltmanDG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med.6(7), e1000097 (2009).
   PubMed Web of Science ®Google Scholar
• Woodward M . Epidemiology: Study Design and Data Analysis (3rd Edition).CRC Press, Taylor & Francis Group, FL, USA (2014).
   Google Scholar
• Hanley JA , McNeilBJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology143(1), 29–36 (1982).
   PubMed Web of Science ®Google Scholar
• Whiting PF , RutjesAW , WestwoodMEet al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med.155(8), 529–536 (2011).
   PubMed Web of Science ®Google Scholar
• Cumpston M , LiT , PageMJet al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev.10, doi: 10.1002/14651858.ED000142 (2019).
   PubMedGoogle Scholar
• Neyeloff JL , FuchsSC , MoreiraLB. Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res. Notes5, 52 (2012).
   PubMedGoogle Scholar
• Altman DG , BlandJM. How to obtain the p value from a confidence interval. BMJ343, doi: 10.1136/bmj.d2304 (2011).
   Google Scholar
• Guyatt GH , OxmanAD , KunzRet al. What is ‘quality of evidence’ and why is it important to clinicians? BMJ 336(7651), 995–998 (2008).
   PubMed Web of Science ®Google Scholar
• Guyatt GH , OxmanAD , VistGEet al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ336(7650), 924–926 (2008).
   PubMed Web of Science ®Google Scholar
• Guyatt G , OxmanAD , AklEAet al. GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. J. Clin. Epidemiol.64(4), 383–394 (2011).
   PubMed Web of Science ®Google Scholar
• Hosseinnezhad T , ShariatiF , TregliaGet al. 99mTc-Pertechnetate imaging for detection of ectopic gastric mucosa: a systematic review and meta-analysis of the pertinent literature. Acta Gastroenterol. Belg.77(3), 318–327 (2014).
   PubMed Web of Science ®Google Scholar
• Sterne JA , EggerM. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J. Clin. Epidemiol.54(10), 1046–1055 (2001).
   PubMed Web of Science ®Google Scholar
• Duval S , TweedieR. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics56(2), 455–463 (2000).
   PubMed Web of Science ®Google Scholar
• Babion I , SnoekBC , NoviantiPWet al. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study. Clin. Epigenetics10, 76 (2018).
   PubMed Web of Science ®Google Scholar
• Bozgeyik E , TepeNB , BozdagZ. Identification of microRNA expression signature for the diagnosis and prognosis of cervical squamous cell carcinoma. Pathol. Res. Pract.216(11), doi: 10.1016/j.prp.2020.153159 (2020).
   PubMed Web of Science ®Google Scholar
• Farzanehpour M , MozhganiSH , JalilvandSet al. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer. Virol. J.16(1), 116 (2019).
   PubMed Web of Science ®Google Scholar
• Jia W , WuY , ZhangQet al. Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol. Clin. Oncol.3(4), 851–858 (2015).
   PubMedGoogle Scholar
• Kawai S , FujiiT , KukimotoIet al. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia. Sci. Rep.8(1), 7070 (2018).
   PubMedGoogle Scholar
• Liu SS , ChanKKL , ChuDKHet al. Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer. Mol. Oncol.12(12), 2009–2022 (2018).
   PubMed Web of Science ®Google Scholar
• Lv A , TuZ , HuangYet al. Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer. Oncol. Lett.21(1), 54 (2021).
   PubMed Web of Science ®Google Scholar
• Park S , EomK , KimJet al. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer17(1), 658 (2017).
   PubMedGoogle Scholar
• Ribeiro J , Marinho-DiasJ , MonteiroPet al. miR-34a and miR-125b expression in HPV infection and cervical cancer development. Biomed. Res. Int.2015, doi: 10.1155/2015/304584 (2015).
   Web of Science ®Google Scholar
• Rogeri CD , SilveiraHCS , CausinRLet al. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer. Gynecol. Oncol.150(3), 545–551 (2018).
   PubMed Web of Science ®Google Scholar
• Tian Q , LiY , WangFet al. MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women. J. Natl Cancer Inst.106(9), doi: 10.1093/jnci/dju241 (2014).
   PubMedGoogle Scholar
• Xie H , NormanI , HjerpeAet al. Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions. Oncol. Lett.13(5), 3586–3598 (2017).
   PubMed Web of Science ®Google Scholar
• Xu J , ZouJ , WuL , LuW. Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinoma. Sci. Rep.10(1), 1–12 (2020).
   PubMed Web of Science ®Google Scholar
• Yang D , ZhangQ. miR-152 may function as an early diagnostic and prognostic biomarker in patients with cervical intraepithelial neoplasia and patients with cervical cancer. Oncol. Lett.17(6), 5693–5698 (2019).
   PubMed Web of Science ®Google Scholar
• Ye J , ChengXD , ChengBet al. MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy. BMC Cancer19(1), 112 (2019).
   PubMedGoogle Scholar
• You W , WangY , ZhengJ. Plasma miR-127 and miR-218 might serve as potential biomarkers for cervical cancer. Reprod. Sci.22(8), 1037–1041 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ZhangD , WangFet al. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. Sci. Rep.5, doi: 10.1038/srep17942 (2015).
   Web of Science ®Google Scholar
• Zheng S , LiR , LiangJet al. Serum miR-638 combined with squamous cell carcinoma-related antigen as potential screening biomarkers for cervical squamous cell carcinoma. Genet Test Mol. Biomarkers24(4), 188–194 (2020).
   PubMed Web of Science ®Google Scholar
• Aftab M , PoojarySS , SeshanVet al. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer. Sci. Rep.11(1), 1–13 (2021).
   PubMed Web of Science ®Google Scholar
• Yu F , LiuJ , DongW , XieJ , ZhaoX. The diagnostic value of miR-145 and miR-205 in patients with cervical cancer. Am. J. Transl. Res.13(3), 1825–1832 (2021).
   PubMed Web of Science ®Google Scholar
• Jiang Y , HuZ , ZuoZet al. Identification of circulating MicroRNAs as a promising diagnostic biomarker for cervical intraepithelial neoplasia and early cancer: a meta-analysis. Biomed. Res. Int.2020, doi: 10.1155/2020/4947381 (2020).
   Web of Science ®Google Scholar
• Xiao C , WanX , YuHet al. LncRNA-AB209371 promotes the epithelial-mesenchymal transition of hepatocellular carcinoma cells. Oncol. Rep.41(5), 2957–2966 (2019).
   PubMed Web of Science ®Google Scholar
• Wang G , LiY , ZhangDet al. CELSR1 acts as an oncogene regulated by miR-199a-5p in glioma. Cancer Manag. Res.12, 8857–8865 (2020).
   PubMed Web of Science ®Google Scholar
• Cheung HH , DavisAJ , LeeTLet al. Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene30(31), 3404–3415 (2011).
   PubMed Web of Science ®Google Scholar
• Qu D , YangY , HuangX. miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma. J. Cell Biochem.120(8), 13562–13572 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang J , YaoT , WangYet al. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. Cancer Biol. Ther.17(1), 104–113 (2016).
   PubMed Web of Science ®Google Scholar
• Han Y , XuGX , LuHet al. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer. Int. J. Clin. Exp. Pathol.8(6), 7131–7139 (2015).
   PubMed Web of Science ®Google Scholar
• Zhu Y , HanY , TianTet al. MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression. Pathol. Res. Pract.214(3), 374–379 (2018).
   PubMed Web of Science ®Google Scholar
• Ma G , SongG , ZouXet al. Circulating plasma microRNA signature for the diagnosis of cervical cancer. Cancer Biomark.26(4), 491–500 (2019).
   PubMed Web of Science ®Google Scholar
• Ni Z , ShenY , WangWet al. miR-141-5p affects the cell proliferation and apoptosis by targeting BTG1 in cervical cancer. Cancer Biother. Radiopharm.doi: 10.1089/cbr.2021.0227 (2021).
   PubMedGoogle Scholar
• Li JH , ZhangZ , DuMZet al. microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2. Arch. Biochem. Biophys.657, 23–30 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang M , ChengS , JinY , ZhaoY , WangY. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim. Biophys. Acta Rev. Cancer1875(2), doi: 10.1016/j.bbcan.2021.188503 (2021).
   Web of Science ®Google Scholar
• Nicholson BD , ShinkinsB , PathirajaIet al. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst. Rev.2015(12), doi: 10.1002/14651858.CD011134.pub2 (2015).
   Google Scholar
• Terentiev AA , MoldogazievaNT. Alpha-fetoprotein: a renaissance. Tumour Biol.34(4), 2075–2091 (2013).
   PubMedGoogle Scholar
• Poruk KE , GayDZ , BrownKet al. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr. Mol. Med.13(3), 340–351 (2013).
   PubMed Web of Science ®Google Scholar
• Whiting PF , DavenportC , JamesonCet al. How well do health professionals interpret diagnostic information? A systematic review. BMJ Open5(7), e008155 (2015).
   PubMed Web of Science ®Google Scholar
• Li MY , HuXX. Meta-analysis of microRNA expression profiling studies in human cervical cancer. Med. Oncol32(6), 510 (2015).
   PubMed Web of Science ®Google Scholar
• He Y , LinJ , DingYet al. A systematic study on dysregulated microRNAs in cervical cancer development. Int. J. Cancer138(6), 1312–1327 (2016).
   PubMed Web of Science ®Google Scholar
• Sabeena S , RavishankarN. Role of microRNAs in predicting the prognosis of cervical cancer cases: a systematic review and meta-analysis. Asian Pac. J. Cancer Prev.22(4), 999–1006 (2021).
   PubMedGoogle Scholar
• Kori M , YalcinArga K. Potential biomarkers and therapeutic targets in cervical cancer: insights from the meta-analysis of transcriptomics data within network biomedicine perspective. PLOS ONE13(7), e0200717 (2018).
   PubMed Web of Science ®Google Scholar
• Dai S , LuY , LongYet al. Prognostic value of microRNAs in cervical carcinoma: a systematic review and meta-analysis. Oncotarget7(23), 35369–35378 (2016).
   PubMedGoogle Scholar
• Chen Z , HanY , SongCet al. Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer. Oncotarget9(24), 17141–17148 (2018).
   PubMedGoogle Scholar
• Nascimento NPG , GallyTB , BorgesGFet al. Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis. BMC Cancer22(1), 862 (2022).
   PubMed Web of Science ®Google Scholar
• Gebrie A . Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: a systematic review and meta-analysis. PLOS ONE17(7), e0268480 (2022).
   PubMed Web of Science ®Google Scholar
• Page MJ , McKenzieJE , BossuytPMet al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ372, doi: 10.1136/bmj.n71 (2021).
   Web of Science ®Google Scholar